Skip to content

Atellica VTLi Sample matrix study for Plasma Separation Membrane Comparison

Atellica VTLi Sample matrix study for Plasma Separation Membrane Comparison - Atellica VTLi Plasma separation Membrane Comparison

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51710
Enrollment
100
Registered
2022-09-28
Start date
2022-06-01
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart attack Myocardial Infarction

Interventions

None listed

Sponsors

Siemens Healthineers
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • >=22 years old • Patients presenting at the coronary care unit with suspected/diagnosed ACS and thus having suspected elevated cTnI values • Patients willing and able to sign informed consent form

Exclusion criteria

Exclusion criteria: • Patients younger than 22 years • Patients requiring emergency treatment • Patients with cognitive impairment or inability to understand study information • Patients previously enrolled in this study • Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frame
The differences between the filters will be analysed using Passing-Bablok regression, according to CLSI EP09c from the Clinical and Laboratory Standards Institute. The parameter to be assessed is the significance of the Passing-Bablok regression, which is performed for each different sample type. Additionally, for each sample type, the measurement results of the filters should demonstrate a correlation coefficient (R) of at least 0.95 Furthermore, the venous whole blood and plasma results as a function of hematocrit for the alternative filter(s) will be analyzed.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)